Matches in Wikidata for { <http://www.wikidata.org/entity/Q84530206> ?p ?o ?g. }
- Q84530206 description "2010 nî lūn-bûn" @default.
- Q84530206 description "2010年の論文" @default.
- Q84530206 description "2010年学术文章" @default.
- Q84530206 description "2010年学术文章" @default.
- Q84530206 description "2010年学术文章" @default.
- Q84530206 description "2010年学术文章" @default.
- Q84530206 description "2010年学术文章" @default.
- Q84530206 description "2010年学术文章" @default.
- Q84530206 description "2010年學術文章" @default.
- Q84530206 description "2010年學術文章" @default.
- Q84530206 description "2010年學術文章" @default.
- Q84530206 description "2010年學術文章" @default.
- Q84530206 description "2010年學術文章" @default.
- Q84530206 description "2010년 논문" @default.
- Q84530206 description "article científic" @default.
- Q84530206 description "article scientific" @default.
- Q84530206 description "article scientifique" @default.
- Q84530206 description "articol științific" @default.
- Q84530206 description "articolo scientifico" @default.
- Q84530206 description "artigo científico" @default.
- Q84530206 description "artigo científico" @default.
- Q84530206 description "artigo científico" @default.
- Q84530206 description "artikel ilmiah" @default.
- Q84530206 description "artikull shkencor" @default.
- Q84530206 description "artikulong pang-agham" @default.
- Q84530206 description "artykuł naukowy" @default.
- Q84530206 description "artículo científico publicado en 2010" @default.
- Q84530206 description "artículu científicu" @default.
- Q84530206 description "bilimsel makale" @default.
- Q84530206 description "bài báo khoa học" @default.
- Q84530206 description "naučni članak" @default.
- Q84530206 description "scienca artikolo" @default.
- Q84530206 description "scientific article published on 03 June 2010" @default.
- Q84530206 description "scientific article published on 3 June 2010" @default.
- Q84530206 description "scientific article published on 3 June 2010" @default.
- Q84530206 description "teaduslik artikkel" @default.
- Q84530206 description "tieteellinen artikkeli" @default.
- Q84530206 description "tudományos cikk" @default.
- Q84530206 description "vedecký článok" @default.
- Q84530206 description "vetenskaplig artikel" @default.
- Q84530206 description "videnskabelig artikel udgivet 3. juni 2010" @default.
- Q84530206 description "vitenskapelig artikkel" @default.
- Q84530206 description "vitskapeleg artikkel" @default.
- Q84530206 description "vědecký článek" @default.
- Q84530206 description "wetenschappelijk artikel" @default.
- Q84530206 description "wissenschaftlicher Artikel" @default.
- Q84530206 description "επιστημονικό άρθρο" @default.
- Q84530206 description "мақолаи илмӣ" @default.
- Q84530206 description "наукова стаття, опублікована в червні 2010" @default.
- Q84530206 description "научна статия" @default.
- Q84530206 description "научная статья" @default.
- Q84530206 description "научни чланак" @default.
- Q84530206 description "научни чланак" @default.
- Q84530206 description "מאמר מדעי" @default.
- Q84530206 description "مقالة علمية نشرت في 3 يونيو 2010" @default.
- Q84530206 description "৩ জুন ২০১০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q84530206 description "บทความทางวิทยาศาสตร์" @default.
- Q84530206 description "სამეცნიერო სტატია" @default.
- Q84530206 name "Pegylated IFN-α2a combined to imatinib mesylate 600mg daily can induce complete cytogenetic and molecular responses in a subset of chronic phase CML patients refractory to IFN alone or to imatinib 600mg daily alone" @default.
- Q84530206 name "Pegylated IFN-α2a combined to imatinib mesylate 600mg daily can induce complete cytogenetic and molecular responses in a subset of chronic phase CML patients refractory to IFN alone or to imatinib 600mg daily alone" @default.
- Q84530206 type Item @default.
- Q84530206 label "Pegylated IFN-α2a combined to imatinib mesylate 600mg daily can induce complete cytogenetic and molecular responses in a subset of chronic phase CML patients refractory to IFN alone or to imatinib 600mg daily alone" @default.
- Q84530206 label "Pegylated IFN-α2a combined to imatinib mesylate 600mg daily can induce complete cytogenetic and molecular responses in a subset of chronic phase CML patients refractory to IFN alone or to imatinib 600mg daily alone" @default.
- Q84530206 prefLabel "Pegylated IFN-α2a combined to imatinib mesylate 600mg daily can induce complete cytogenetic and molecular responses in a subset of chronic phase CML patients refractory to IFN alone or to imatinib 600mg daily alone" @default.
- Q84530206 prefLabel "Pegylated IFN-α2a combined to imatinib mesylate 600mg daily can induce complete cytogenetic and molecular responses in a subset of chronic phase CML patients refractory to IFN alone or to imatinib 600mg daily alone" @default.
- Q84530206 P1433 Q84530206-B085DF12-FA05-4D1A-AFA0-EBDE03E656D2 @default.
- Q84530206 P1476 Q84530206-0934635C-1940-4448-8220-2996F29CDD66 @default.
- Q84530206 P2093 Q84530206-176E86D4-C33B-43EB-951F-FD3E322FEF82 @default.
- Q84530206 P2093 Q84530206-17EAB471-3FFA-46DE-934C-AF80C8C996B0 @default.
- Q84530206 P2093 Q84530206-1B20891E-4272-4EE1-901E-686B1B3F940C @default.
- Q84530206 P2093 Q84530206-1DF76777-172D-40A7-9A17-9D8A4C44EF95 @default.
- Q84530206 P2093 Q84530206-1EA42EF6-4758-478B-8DFD-42D94435363F @default.
- Q84530206 P2093 Q84530206-49574209-C01C-4228-9B8E-770417C39226 @default.
- Q84530206 P2093 Q84530206-50157BED-1642-466B-BE88-D1723E1137A1 @default.
- Q84530206 P2093 Q84530206-62B23243-D913-4E66-911B-935B1BF319B5 @default.
- Q84530206 P2093 Q84530206-8B422525-AE41-4A7C-9B3F-F8FC7B5BA6EC @default.
- Q84530206 P2093 Q84530206-B35A911F-5C5D-4410-97B6-E654017486CF @default.
- Q84530206 P2093 Q84530206-D1ABA08B-AFEF-4A9E-87D0-07644B9E7ADA @default.
- Q84530206 P2093 Q84530206-F2006542-D8BA-4151-803F-4CCB6ABD2C28 @default.
- Q84530206 P2093 Q84530206-FA26D83F-B23A-4376-8356-B9DA77D1F855 @default.
- Q84530206 P2093 Q84530206-FBCF8324-A919-4278-9B83-40093EA3EB2F @default.
- Q84530206 P304 Q84530206-1FAE917A-54CC-40A2-927E-61968F00F3A2 @default.
- Q84530206 P31 Q84530206-BE4DB9D4-ABEE-4881-AE6A-732E45BC177A @default.
- Q84530206 P356 Q84530206-C9496F31-7BD7-4B94-8CFC-66D981FFD8A1 @default.
- Q84530206 P433 Q84530206-3E7621A6-E81C-4AF6-9734-B4E4E1879130 @default.
- Q84530206 P478 Q84530206-71B33952-E63E-450C-ABDF-7CE7461250A0 @default.
- Q84530206 P50 Q84530206-500C13B0-2A39-488D-AE4A-646C36436B14 @default.
- Q84530206 P577 Q84530206-293DE7CE-315A-4CF8-BC5C-0EA17B2F48D2 @default.
- Q84530206 P698 Q84530206-48C4BA4C-4181-4A0D-ACD6-675895C70CDA @default.
- Q84530206 P921 Q84530206-C64F05AC-4572-407D-BD5C-086005FA0F63 @default.
- Q84530206 P356 J.LEUKRES.2010.04.010 @default.
- Q84530206 P698 20605207 @default.
- Q84530206 P1433 Q15716445 @default.
- Q84530206 P1476 "Pegylated IFN-α2a combined to imatinib mesylate 600mg daily can induce complete cytogenetic and molecular responses in a subset of chronic phase CML patients refractory to IFN alone or to imatinib 600mg daily alone" @default.
- Q84530206 P2093 "Agnès Guerci" @default.
- Q84530206 P2093 "Aude Charbonnier" @default.
- Q84530206 P2093 "Carole Paillet" @default.
- Q84530206 P2093 "Christine Pivot" @default.
- Q84530206 P2093 "Franck E Nicolini" @default.
- Q84530206 P2093 "Françoise Rigal-Huguet" @default.